The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

The startup is working on small, light motors with no rare-earth magnets that are suited for drones, fans, and robots.

As concern over AI safety and rogue agents continue to make headlines, it’s no surprise that cybersecurity stocks are rising, or that investors are pouring massive amounts of capital into startups trying to build the next generation of security for an AI-native world. We’re even seeing companies like Instinct and Simile bring in nine-figure checks and valuations that wouldn’t have made sense a […]

The Amazon-owned company launched an investigation after a worker submitted an OSHA complaint.